166 related articles for article (PubMed ID: 32430256)
1. Elastography of pancreatic ductal adenocarcinoma following EUS-guided radiofrequency ablation (with video).
Mazzawi T; Chaiyapo A; Kongkam P; Ridtitid W; Rerknimitr R
Arab J Gastroenterol; 2020 Jun; 21(2):128-131. PubMed ID: 32430256
[TBL] [Abstract][Full Text] [Related]
2. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
[TBL] [Abstract][Full Text] [Related]
3. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation.
Lawrence PV; Desai K; Wadsworth C; Mangal N; Kocher HM; Habib N; Sadanandam A; Sodergren MH
Curr Oncol; 2022 Sep; 29(10):6754-6763. PubMed ID: 36290808
[TBL] [Abstract][Full Text] [Related]
4. Intraductal radiofrequency ablation of an intraductal papillary mucinous neoplasia of the main pancreatic duct.
Lorenzo D; Barret M; Bordacahar B; Leblanc S; Chaussade S; Cattan P; Prat F
Endoscopy; 2018 Feb; 50(2):176-177. PubMed ID: 29169194
[No Abstract] [Full Text] [Related]
5. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinoma.
Furnica RM; Deprez P; Maiter D; Vandeleene B; Borbath I
Ann Endocrinol (Paris); 2020 Dec; 81(6):567-571. PubMed ID: 33285105
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Borrelli de Andreis F; Boškoski I; Mascagni P; Schepis T; Bianchi A; Schinzari G; Annicchiarico BE; Quero G; Tortora G; Alfieri S; Gasbarrini A; Costamagna G; Spada C; Attili F
Pancreatology; 2023 Aug; 23(5):543-549. PubMed ID: 37236853
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography.
Yamada K; Kawashima H; Ohno E; Ishikawa T; Tanaka H; Nakamura M; Miyahara R; Ishigami M; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Mar; 20(1):81. PubMed ID: 32228472
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies.
Khoury T; Sbeit W; Napoléon B
World J Gastroenterol; 2023 Jan; 29(1):157-170. PubMed ID: 36683710
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound-guided radiofrequency ablation of unresectable pancreatic cancer with low ablation power and multiple applications: a preliminary study of 11 patients.
Wang J; Wang Y; Zhao Y; Wu X; Zhang M; Hou W; Chen Q; Cheng B
Ann Palliat Med; 2021 Feb; 10(2):1842-1850. PubMed ID: 33440967
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
Armellini E; Facciorusso A; Crinò SF
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
[No Abstract] [Full Text] [Related]
14. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
15. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos).
Bang JY; Sutton B; Hawes RH; Varadarajulu S
Gastrointest Endosc; 2019 Jan; 89(1):58-66.e3. PubMed ID: 30120957
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasonography-guided tumor ablation.
Lakhtakia S; Seo DW
Dig Endosc; 2017 May; 29(4):486-494. PubMed ID: 28171697
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors.
Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
Endoscopy; 2018 Nov; 50(11):1099-1104. PubMed ID: 29727904
[TBL] [Abstract][Full Text] [Related]
18. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ablation therapy for the pancreatic neoplasms.
Matsumoto K; Kato H
Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
